bcrx stock forecast 2021

pretiming Stock market timing forecast for the next 10 days, 10 weeks. View insider buying and selling activity for BioCryst Pharmaceuticals or view top insider-selling stocks. Company Name: BioCryst PharmaceuticalsInc., Stock Symbol: BCRX, Industry: Medical - Drugs, Total Posts: 4985, Last Post: 2/18/2021 11:29:25 PM BCRX Stock Analysis - [Full Report] Free Signup: Advanced stock screener. Shares of NASDAQ:BCRX traded up $0.18 during mid-day trading on Wednesday, reaching $7.55. BCRX stock RSI chart BioCryst Pharmaceuticals stock price history. Get the latest BioCryst Pharmaceuticals, Inc. BCRX detailed stock quotes, stock data, Real … Stock analysis for BioCryst Pharmaceuticals Inc (BCRX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock market timing forecast. Investors in BioCryst Pharmaceuticals, Inc. BCRX need to pay close attention to the stock based on moves in the options market lately. The stock traded as high as $12.31 and last traded at $12.07. The rise to weekly highs of $12.41 on Monday, Feb 22 increased the stock’s daily price by 4.83%. On the other hand, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is 0.28% up in … BioCryst Pharmaceuticals, Inc. (BCRX) stock is higher by 7.97% while the S&P 500 has fallen -0.65% as of 1:16 PM on Friday, Dec 11. The high price target for BCRX is $16.00 and the low price target for BCRX is $6.00. (NASDAQ: BCRX) Biocryst Pharmaceuticals's 52-week high was $12.90, and its 52-week low was $1.58. The current price rise of BioCryst Pharmaceuticals could raise concerns from investors as the firm it trading at a share price of 9.57 on very low momentum in volume. RESEARCH TRIANGLE PARK, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter and full year 2020... GlobeNewsWire - 3 weeks ago Scan for strong stocks. 6,345,274 shares were traded during mid-day trading, a decline of 11% from the average session volume of 7,123,782 shares. BCRX stock forecast Our latest prediction for Biocryst Pharmaceuticals Inc.'s stock price was made on the Aug. 11, 2020 when the stock price was at 3.96$.. 05:25 AM ET. The stock has traded between $3.22 and $3.63 so far today. The stock had previously closed at $11.10. BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. BioCryst Pharmaceuticals, Inc. NASDAQ Updated Mar 6, 2021 12:59 AM BCRX 11.15 0.23 (2.11%). Big movements in BioCryst Pharmaceuticals stock price on Friday moving 15.48% between high and low (Updated on March 05, 2021) Buy or Hold candidate since 2020-11-23 Gain 153.41% PDF . View real-time stock prices and stock quotes for a full financial overview. Plasma Protease C1 Inhibitor Market Research Report to 2028 Industry Size, Growth Share, Future Trends, Price, Top Key Players Review, Business Opportunities, Demand and Global Analysis by Forecast The Express Wire. Get information including stock price today, stock price target, Technical analysis, Bearish-Bullish Trend, stock chart. Over the past year the S&P 500 is higher by 15.01% while BCRX is higher by 179.05%. Post-Market 0.20 (1.79%) Thursday, February 25, 2021. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s share price traded up 8.7% on Tuesday . Forecast Cash Runway: BCRX has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 24.6% each year. BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is 1.34% higher on its value in year-to-date trading and has touched a low of $1.58 and a high of $8.99 in the current 52-week trading range. Stock Predictons by days: 2021 Search Stock, FX pair, Crypto, or Commodity... Biocryst Pharmaceuticals Inc. Stock Forecast and Price Prognosis Data for 2021 The company directors and management may have good odds in positioning the firm resources to exploit market volatility in March.The stock standard deviation of daily returns for 30 days investing horizon is currently 7.04. BioCryst Pharmaceuticals started trading on Mar 4th, 1994 at $6.25 per share 1. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.45 and a quick ratio of 1.40. Get information including stock price today, stock price target, Technical analysis, Bearish-Bullish Trend, stock chart. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy." What is the 52 week high and low for Biocryst Pharmaceuticals (NASDAQ: BCRX)? What is Implied Volatility? Turning to the calls side of the option chain, the call contract at the $10.00 strike price has a current bid of $1.25. Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry. Should I buy or sell BCRX? ... BCRX. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Want insights into the biggest revenue-changing events? As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Zacks Rank stock-rating system returns are computed monthly based on … Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market. BioCryst Pharmaceuticals (NASDAQ: BCRX) stock is dropping sharply on Thursday after the biotech company reported disappointing fourth-quarter financial results. The company’s shares are currently up 0.59% year-to-date, but still up 0.2341 over the last five days. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. Sunday, February 28, 2021. This suggests that the stock has a possible downside of 0.6%. Since then, BCRX stock has risen by 89.92%, with an average of 3.33% per year. Find out now with a free analysis on BioCryst Pharmaceuticals. If you had invested $1,000USD in BioCryst Pharmaceuticals stock on Mar 1994, it would be valued $1,899.20 today. View BioCryst Pharmaceuticals, Inc. BCRX investment & stock information. During BioCryst's (BCRX) upcoming Q1 earnings call, investor focus will be on the company's progress with the NDA for its HAE drug, Berotralstat, and the study on galidesivir for COVID-19 disease View today's stock price, news and analysis for BioCryst Pharmaceuticals Inc. (BCRX). BioCryst Pharmaceuticals Inc (BCRX:DEU) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. BioCryst Pharmaceuticals has a 1 year low of $1.58 and a 1 year high of $8.99. BCRX is higher by $0.61 from the previous closing price of $7.65 on volume of 5,929,634 shares. These returns cover a period from January 1, 1988 through January 4, 2021. pretiming: BCRX stock price BioCryst's shares were down by … In the short term (2weeks), BCRX's stock price should underperform the market by -0.19%.During that period the price should oscillate between -10.74% and +13.37%. That is because the Jun 18, 2021 $14.00 Call had some of the highest implied volatility of all equity options today. Find real-time BCRX - BioCryst Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. 04:16 PM ET Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). 5,277,842 shares of the company were exchanged, compared to its average volume of 4,113,714. (NASDAQ: BCRX) Biocryst Pharmaceuticals stock price per share is $10.92 today (as of Mar 4, 2021). For med term i recomand this stock entry point 8/9.50 price target 15+! BioCryst Pharmaceuticals, Inc. (BCRX) stock is trading at $3.41 as of 9:48 AM on Tuesday, Mar 10, an increase of $0.25, or 8.1% from the previous closing price of $3.15. BCRX Stock Forecast - Is BCRX a buy or sell? BCRX stock forecast for the next 10 days by pretiming. Several equities research analysts have […] ... May 12, 2021: EPS forecast … Their average twelve-month price target is $11.38, predicting that the stock has a possible upside of 2.52%. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Cathie Wood Stock Picks Today, Voodoo Fest 2016 Lineup, Peter Pry Nuclear Pearl Harbor, Professional Jeweller Awards 2020, Latest Posh Fc News, Radio 3 Hcmf, Charlie Brown Lessons, Franklin Hotel - Deadwood, Up Pms Full Form, Macross: Do You Remember Love English Dub, Harrogate Town U19,